No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs555948613 |
chr3:53837716-53837717 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs3774610 |
chr3:53837755-53837756 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs59314090 |
chr3:53837788-53837789 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs9849534 |
chr3:53837823-53837824 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs116459764 |
chr3:53837840-53837841 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs189557335 |
chr3:53837874-53837875 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs145596013 |
chr3:53837904-53837905 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs4687586 |
chr3:53837971-53837972 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
9 |
rs180855592 |
chr3:53837973-53837974 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs570304309 |
chr3:53837976-53837977 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs532715619 |
chr3:53837977-53837978 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs140390958 |
chr3:53838015-53838016 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs571332695 |
chr3:53838018-53838019 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs533621367 |
chr3:53838044-53838045 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs75551622 |
chr3:53838050-53838051 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs553354288 |
chr3:53838068-53838069 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs566881643 |
chr3:53838080-53838081 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs76047132 |
chr3:53838102-53838103 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs556038273 |
chr3:53838127-53838128 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs185366207 |
chr3:53838131-53838132 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs146415536 |
chr3:53838154-53838155 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs562712050 |
chr3:53838183-53838184 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs190177596 |
chr3:53838201-53838202 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs375746301 |
chr3:53838206-53838207 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs533668444 |
chr3:53838227-53838228 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs561279088 |
chr3:53838228-53838229 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs530010808 |
chr3:53838306-53838307 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs548528487 |
chr3:53838320-53838321 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs544153734 |
chr3:53838335-53838336 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs72979962 |
chr3:53838352-53838353 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs532658966 |
chr3:53838402-53838403 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs552757286 |
chr3:53838404-53838405 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs559643532 |
chr3:53838411-53838412 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs567632635 |
chr3:53838431-53838432 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs527389787 |
chr3:53838436-53838437 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs547079568 |
chr3:53838455-53838456 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs182840944 |
chr3:53838492-53838493 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs535825125 |
chr3:53838536-53838537 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs186899305 |
chr3:53838544-53838545 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs114765269 |
chr3:53838549-53838550 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs192244368 |
chr3:53838560-53838561 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs117466749 |
chr3:53838568-53838569 |
Enhancers Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs549237305 |
chr3:53838644-53838645 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs566156257 |
chr3:53838661-53838662 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs572107534 |
chr3:53838671-53838672 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs571602918 |
chr3:53838709-53838710 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs183662011 |
chr3:53838714-53838715 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs140939828 |
chr3:53838750-53838751 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs574918460 |
chr3:53838753-53838754 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs570175693 |
chr3:53838755-53838756 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|